TY - JOUR
T1 - The Pediatric Neurology 2020 Research Workforce Survey
T2 - Optimism in a Time of Challenge
AU - Bonkowsky, Joshua L.
AU - Felling, Ryan J.
AU - Grinspan, Zachary M.
AU - Guerriero, Réjean M.
AU - Kosofsky, Barry E.
AU - Lyons-Warren, Ariel M.
AU - deVeber, Gabrielle A.
N1 - Funding Information:
Disclosures: J.L.B.: Consultant: Bluebird Bio, Calico, Enzyvant, Denali Therapeutics, Neurogene; Board of Directors: wFluidx; Stock: Orchard Therapeutics; Royalties: Manson Publishing, BioMerieux (spouse). Research support: NIH; Vanishing White Matter Foundation. R.J.F.: Research support: NIH. Z.M.G.: Consultant: Bio-pharm Solutions; AlphaInsights. Research support: Pediatric Epilepsy Research Foundation, Weill Cornell Medicine, BAND Foundation, Epilepsy Foundation, and the Morris and Alma Schapiro Fund. R.M.G.: Research support: Washington University in St. Louis ICTS. B.E.K.: President and Founder, ANSwers Neuroscience. A.M.L.-W.: Research Support: Child Neurology Career Development Program K12. G.A.d.: Research Support: NIH; Consultant: Johnson and Johnson (Janssen); Stock: Nono Inc (spouse); Thornhill Medical (spouse).
Publisher Copyright:
© 2020
PY - 2021/3
Y1 - 2021/3
N2 - Background: The past decades have seen a transformational shift in the understanding and treatment for neurological diseases affecting infants and children. These advances have been driven in part by the pediatric neurology physician-scientist workforce and its efforts. However, pediatric neurology research faces significant challenges from internal and external forces including work-life balance demands, COVID-19 pandemic effects, and research funding. Understanding the impact of these challenges on the perceptions, planning, and careers of pediatric neurology physician-scientists is needed to guide the research mission. Methods: Our objective was to survey the research challenges, goals, and priorities of pediatric neurologists. In 2020 we conducted a cross-sectional, 28-question survey emailed to 1,775 members of the Child Neurology Society. Results: One hundred fifty-one individuals responded to the survey. Most respondents were grant investigators (52%) and conducted clinical research (69%). Research areas included epilepsy (23%), neurodevelopmental and autism (16%), neurocritical care and stroke (11%), neurogenetics and neurometabolics (9%), neonatal neurology (8%), and others. The most common funding source was the National Institutes of Health (37%). Shared major research concerns were funding, utilization of remote technology, overcoming disparities, natural history and multicenter studies, global neurology, and diversification of the research portfolio. Commitment to continuing and increasing research efforts was evident. Conclusions: Our survey demonstrates obstacles for physician-scientist researchers in pediatric neurology, but it also shows optimism about continued opportunity. Creative approaches to address challenges will benefit the research mission, maximize the current and future pool of researchers, and help improve the lives of children with neurological disorders.
AB - Background: The past decades have seen a transformational shift in the understanding and treatment for neurological diseases affecting infants and children. These advances have been driven in part by the pediatric neurology physician-scientist workforce and its efforts. However, pediatric neurology research faces significant challenges from internal and external forces including work-life balance demands, COVID-19 pandemic effects, and research funding. Understanding the impact of these challenges on the perceptions, planning, and careers of pediatric neurology physician-scientists is needed to guide the research mission. Methods: Our objective was to survey the research challenges, goals, and priorities of pediatric neurologists. In 2020 we conducted a cross-sectional, 28-question survey emailed to 1,775 members of the Child Neurology Society. Results: One hundred fifty-one individuals responded to the survey. Most respondents were grant investigators (52%) and conducted clinical research (69%). Research areas included epilepsy (23%), neurodevelopmental and autism (16%), neurocritical care and stroke (11%), neurogenetics and neurometabolics (9%), neonatal neurology (8%), and others. The most common funding source was the National Institutes of Health (37%). Shared major research concerns were funding, utilization of remote technology, overcoming disparities, natural history and multicenter studies, global neurology, and diversification of the research portfolio. Commitment to continuing and increasing research efforts was evident. Conclusions: Our survey demonstrates obstacles for physician-scientist researchers in pediatric neurology, but it also shows optimism about continued opportunity. Creative approaches to address challenges will benefit the research mission, maximize the current and future pool of researchers, and help improve the lives of children with neurological disorders.
KW - Career
KW - Child neurology
KW - Funding
KW - Physician-scientist
KW - Survey
KW - Workforce
UR - http://www.scopus.com/inward/record.url?scp=85099627296&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099627296&partnerID=8YFLogxK
U2 - 10.1016/j.pediatrneurol.2020.11.020
DO - 10.1016/j.pediatrneurol.2020.11.020
M3 - Article
C2 - 33486423
AN - SCOPUS:85099627296
SN - 0887-8994
VL - 116
SP - 62
EP - 67
JO - Pediatric Neurology
JF - Pediatric Neurology
ER -